Síndrome MEN I y otros tumores neuroendocrinos gastroenteropancreáticos poco frecuentesestrategia terapéutica y resultados

Referencias bibliográficas

• Rich T.A., Perrier N.D. Multiple endocrine neoplasia syndromes. Surg Clin N Am. 2008; 88: 863-895.
• Piecha G., Chudek J., Wiecek A. Multiple endocrine neoplasia type 1. European Journal of Internal Medicine 2008; 19: 99-103.
• Bartsch D.K., Fendrich V., Langer P., Celik I., Kann P.H., Rothmund M. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2005; 242(6): 757-766.
• Tonelli F., Fratini G., Falchetti A., Nesi G., Brandi L. Surgery for gastroenteropacreatic tumours in multiple endocrine neoplasia type 1: review and personal experience. J Inter Med. 2005; 257: 38-49.
• Falchetti A., Marini F., Luzi E., Tonelli F., Brandt M.L. Multiple endocrine neoplasms. Best Practice & Research Clinical Rheumatology. 2008; 22(1): 149-163
• Doherty G M. Multiple Endocrine Neoplasia Type 1. J Surg Oncol. 2005; 89: 143-150.
• Sitges-Serra A., Sancho Insenser J., Casanova Retuerto D. El hiperparatiroidismo primario en el contexto de una neoplasia endocrina múltiple. En: Cirugía Endocrina (Guía Clínica de la Asociación Española de Cirujanos). Ed. Aran 1999: 109-111.
• You Y.N., Thompson G.B., Young W.F., Larson D., Farley D.R., Richards M., Grant C.S. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery.2007; 142: 829- 836.
• Alexakis N., Neoptolemos J.P. Pancreatic neuroendocrine tumours. Best Practice & Research Clinical Gastroenterology. 2008; 22(1): 183-205.
• Fernández-Cruz L., Romero J., Zelaya R., Olvera C., Maglio L. Surgical strategies for nonfunctioning pancreatic tumors and for other pancreatic neoplasms associated with multiple endocrine neoplasia type 1. The American Journal of Surgery. 2007; 194(supl Oct 2007): S143-S147.
• Akerstrom G., Hessman O. Pancreatic tumours as part of the MEN-I syndrome. 2005; 19(5): 819-830
• Hausman M.S., Thompson N.W., Gauger P.G., Doherty G.M. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery. 2004; 136: 1205-1211.
• The S.H., Deveney C., Sheppard B.C. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable. The American Journal of Surgery. 2007; 193: 610-613.
• Tonelli F., Fratini G., Nesi G., Tommasi M.S., Batignani G., Falchetti A., Brandi M.L.. Pancreatectomy in Multiple Endocrine Neoplasia Type 1-related Gastrinomas and Pancreatic Endocrine neoplasias. Ann Surg.2006; 244: 61-70.
• Norton J.A. Surgical treatment and prognosis of gastrinoma. Best Practice & Research Clinical Gastroenterology. 2005; 19(5): 799- 805.
• Gomez-Rivera F., Stewart A.E., Arnoletti J.P., Vickers S., Bland K.I., Heslin M.J. Surgical treatment of pancreatic endocrine neoplasm. The American Journal of Surgery.2007; 193: 460-465.
• Sanchez-Pernaute A., Perez-Aguirre M.E., Talavera-Eguizabal P., Torres-García A. Tratamiento quirúrgico de los tumoures neuroendocrinos gastroenteropancreáticos. Endocrinol Nutr.2007; 54(supl 1): 38-43.
• Clark OH, Duh Q-Y. Textbook of endocrine Surgery. Saunders, Philadelphia 1997; 599-605.
• Sitges-Serra A, Insenser JS. Cirugía Endocrina. Asociación Española de Cirujanos, Madrid 1999; 203-220.
• Parrilla Paricio P, Jaurrieta Mas E, Moreno Azcoitia M. Cirugía AEC: Manual de la Asociación Española de Cirujanos. Médica Panamericana, Madrid 2004; 696-702.
• Poston GJ, Blumgart LH. Surgical Management of Hepatobiliary and Pancreatic Disorders. Martin Dunitz Taylor & Francis group, London 2003; 369-391.
• O’ Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. EJSO. 2008; 34: 324-332.
• Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. British Journal of Surgery. 2006; 93: 264-275
• Grant CS. Insulinoma. Best Practice & Research Clinical Gastroenterology. 2005; 19(5): 783-798.
• AKerström G, Hellman P. Surgery on neuroendocrine tumours. Best Practice & Research Clinical Endocrinology & Metabolism. 2007; 21(1): 87-109
• Van Beek AP, De Haas ERM, Van Bloten WA, Lips CIM, Roijers JFM, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. European Journal of Endocrinology . 2004; 151: 531-537
• Doherty GM. Rare endocrine tumours of the GI tract. Best Practice & Research Clinical Gastroenterology. 2005; 19(5): 807-817
• Kaltsas G. A., Besser G.M., Grossman A.B. The diagnosis and medical management of advanced neuroendocrine tumors. EndocrRew 2004;25(3):458-511.
• Aller J., Domínguez R., Estrada J. Otros tumores neuroendocrinos pancreaticos: glucagonomas, VIPomas, somatostatinomas, no funcionantes y tumores con secrecion ectopica. Enocrinol Nutr. 2007;54(Supl 1): 31-37.
• Mignon M 2000 Natural history of neuroendocrine enteropancreatic tumors. Digestion 62(Suppl 1):51–58
• Kouvaraki, M.A., Solórzano, C.C., Shapiro, S.E., Yao, J.C., Perrier, N.D., Lee, J.E., Evans, D.B. Surgical treatment of non-functioning pancreatic islet cell tumors.
• Thompson, N.W. Multiple endocrine neoplasia type 1. Surgical therapy. Cancer Treat Res 1997; 89:407-419.
• Malbrut, J.Y., Fernández-Cruz, L., Azagra, J.S. Bass, C. Delvaux, G. Weerts, J. et al. Laparoscopic pancreatic resection: Result of a multicentric European study of 127 patients. Surgery 2005;137:597-605